{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:29:08Z","timestamp":1774405748838,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Scientific Foundation of China","doi-asserted-by":"crossref","award":["81901586"],"award-info":[{"award-number":["81901586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Scientific Foundation of China","doi-asserted-by":"crossref","award":["81771754"],"award-info":[{"award-number":["81771754"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tongji Hospital Clinical Research Flagship Program","award":["2019CR206"],"award-info":[{"award-number":["2019CR206"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10067-022-06369-8","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T13:04:00Z","timestamp":1664197440000},"page":"101-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical characteristics of SLE patients infected with Epstein-Barr virus and potential associated risk factors"],"prefix":"10.1007","volume":"42","author":[{"given":"Bingxia","family":"Ming","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaozhe","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jixin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-1125","authenticated-orcid":false,"given":"Lingli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"6369_CR1","doi-asserted-by":"crossref","unstructured":"YC Kwon, S Chun, K Kim, A Mak (2019) Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond. Cells 8(10).","DOI":"10.3390\/cells8101180"},{"issue":"2","key":"6369_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/03009749109165285","volume":"20","author":"KL Wong","year":"1991","unstructured":"Wong KL, Hawkins BR, Wong RW (1991) Immunogenetics in Chinese patients with SLE. Scand J Rheumatol 20(2):110\u2013114","journal-title":"Scand J Rheumatol"},{"key":"6369_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2013.01.008","volume":"41","author":"Y Cui","year":"2013","unstructured":"Cui Y, Sheng Y, Zhang X (2013) Genetic susceptibility to SLE: recent progress from GWAS. J Autoimmun 41:25\u201333","journal-title":"J Autoimmun"},{"issue":"4","key":"6369_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.autrev.2008.12.008","volume":"8","author":"BD Poole","year":"2009","unstructured":"Poole BD, Templeton AK, Guthridge JM, Brown EJ, Harley JB, James JA (2009) Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. Autoimmun Rev 8(4):337\u2013342","journal-title":"Autoimmun Rev"},{"issue":"10","key":"6369_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1177\/0961203320940029","volume":"29","author":"D Aygun","year":"2020","unstructured":"Aygun D, Kuskucu MA, Sahin S, Adrovic A, Barut K, Yildiz M, Sharifova S, Midilli K, Cokugras H, Camcioglu Y, Kasapcopur O (2020) Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity. Lupus 29(10):1263\u20131269","journal-title":"Lupus"},{"issue":"3","key":"6369_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00430-004-0230-5","volume":"194","author":"SF Yu","year":"2005","unstructured":"Yu SF, Wu HC, Tsai WC, Yen JH, Chiang W, Yuo CY, Lu SN, Chiang LC, Chen CJ (2005) Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in Taiwan. Med Microbiol Immunol 194(3):115\u2013120","journal-title":"Med Microbiol Immunol"},{"issue":"1","key":"6369_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10238-018-0535-0","volume":"19","author":"ZX Li","year":"2019","unstructured":"Li ZX, Zeng S, Wu HX, Zhou Y (2019) The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis. Clin Exp Med 19(1):23\u201336","journal-title":"Clin Exp Med"},{"issue":"6","key":"6369_CR8","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s12026-018-9045-0","volume":"66","author":"DH Dreyfus","year":"2018","unstructured":"Dreyfus DH, Farina A, Farina GA (2018) Molecular mimicry, genetic homology, and gene sharing proteomic \u201cmolecular fingerprints\u201d using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease. Immunol Res 66(6):686\u2013695","journal-title":"Immunol Res"},{"issue":"2","key":"6369_CR9","first-page":"523","volume":"18","author":"A Piroozmand","year":"2017","unstructured":"Piroozmand A, Haddad Kashani H, Zamani B (2017) Correlation between Epstein-Barr virus infection and disease activity of systemic lupus erythematosus: a cross-sectional study. Asian Pac J Cancer Prev 18(2):523\u2013527","journal-title":"Asian Pac J Cancer Prev"},{"issue":"9","key":"6369_CR10","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/annrheumdis-2019-215361","volume":"78","author":"NR Jog","year":"2019","unstructured":"Jog NR, Young KA, Munroe ME, Harmon MT, Guthridge JM, Kelly JA, Kamen DL, Gilkeson GS, Weisman MH, Karp DR, Gaffney PM, Harley JB, Wallace DJ, Norris JM, James JA (2019) Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann Rheum Dis 78(9):1235\u20131241","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6369_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jmv.24904","volume":"90","author":"D Chougule","year":"2018","unstructured":"Chougule D, Nadkar M, Rajadhyaksha A, Pandit-Shende P, Surve P, Dawkar N, Khadilkar P, Patwardhan M, Kaveri S, Ghosh K, Pradhan V (2018) Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile. J Med Virol 90(3):559\u2013563","journal-title":"J Med Virol"},{"issue":"5","key":"6369_CR12","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D","volume":"44","author":"JA James","year":"2001","unstructured":"James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, Harley JB (2001) Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 44(5):1122\u20131126","journal-title":"Arthritis Rheum"},{"issue":"4","key":"6369_CR13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/art.20997","volume":"52","author":"CG Parks","year":"2005","unstructured":"Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP (2005) Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 52(4):1148\u20131159","journal-title":"Arthritis Rheum"},{"issue":"1","key":"6369_CR14","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/ar4429","volume":"16","author":"P Hanlon","year":"2014","unstructured":"Hanlon P, Avenell A, Aucott L, Vickers MA (2014) Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus. Arthritis Res Ther 16(1):R3","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"6369_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00296-010-1573-4","volume":"32","author":"BA Esen","year":"2012","unstructured":"Esen BA, Yilmaz G, Uzun S, Ozdamar M, Aksozek A, Kamali S, Turkoglu S, Gul A, Ocal L, Aral O, Inanc M (2012) Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study. Rheumatol Int 32(1):79\u201383","journal-title":"Rheumatol Int"},{"issue":"13","key":"6369_CR16","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1177\/0961203309345729","volume":"18","author":"Y Berkun","year":"2009","unstructured":"Berkun Y, Zandman-Goddard G, Barzilai O, Boaz M, Sherer Y, Larida B, Blank M, Anaya JM, Shoenfeld Y (2009) Infectious antibodies in systemic lupus erythematosus patients. Lupus 18(13):1129\u20131135","journal-title":"Lupus"},{"issue":"3","key":"6369_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00296-003-0420-2","volume":"25","author":"ML Huggins","year":"2005","unstructured":"Huggins ML, Todd I, Powell RJ (2005) Reactivation of Epstein-Barr virus in patients with systemic lupus erythematosus. Rheumatol Int 25(3):183\u2013187","journal-title":"Rheumatol Int"},{"issue":"2","key":"6369_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000045391","volume":"82","author":"P Stratta","year":"1999","unstructured":"Stratta P, Canavese C, Ciccone G, Santi S, Quaglia M, Ghisetti V, Marchiaro G, Barbui A, Fop F, Cavallo R, Piccoli G (1999) Correlation between cytomegalovirus infection and Raynaud\u2019s phenomenon in lupus nephritis. Nephron 82(2):145\u2013154","journal-title":"Nephron"},{"issue":"3","key":"6369_CR19","doi-asserted-by":"publisher","first-page":"e0193171","DOI":"10.1371\/journal.pone.0193171","volume":"13","author":"J Cui","year":"2018","unstructured":"Cui J, Yan W, Xu S, Wang Q, Zhang W, Liu W, Ni A (2018) Anti-Epstein-Barr virus antibodies in Beijing during 2013\u20132017: what we have found in the different patients. PLoS ONE 13(3):e0193171","journal-title":"PLoS ONE"},{"issue":"4","key":"6369_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jcv.2010.08.015","volume":"49","author":"DY Chen","year":"2010","unstructured":"Chen DY, Chen YM, Lan JL, Chen HH, Hsieh CW, Wey SJ, Lu JJ (2010) Polymyositis\/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection? J Clin Virol 49(4):290\u2013295","journal-title":"J Clin Virol"},{"issue":"3","key":"6369_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/0961203306075800","volume":"16","author":"JJ Lu","year":"2007","unstructured":"Lu JJ, Chen DY, Hsieh CW, Lan JL, Lin FJ, Lin SH (2007) Association of Epstein-Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus 16(3):168\u2013175","journal-title":"Lupus"},{"issue":"2","key":"6369_CR22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","volume":"172","author":"I Kang","year":"2004","unstructured":"Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J (2004) Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 172(2):1287\u20131294","journal-title":"J Immunol"},{"issue":"10","key":"6369_CR23","doi-asserted-by":"publisher","first-page":"e1002328","DOI":"10.1371\/journal.ppat.1002328","volume":"7","author":"M Larsen","year":"2011","unstructured":"Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, Miyara M, Boutolleau D, Parizot C, Dorgham K, Papagno L, Appay V, Amoura Z, Gorochov G (2011) Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog 7(10):e1002328","journal-title":"PLoS Pathog"},{"issue":"11","key":"6369_CR24","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1002\/jmv.23670","volume":"85","author":"F Broccolo","year":"2013","unstructured":"Broccolo F, Drago F, Cassina G, Fava A, Fusetti L, Matteoli B, Ceccherini-Nelli L, Sabbadini MG, Lusso P, Parodi A, Malnati MS (2013) Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases. J Med Virol 85(11):1925\u20131934","journal-title":"J Med Virol"},{"issue":"4","key":"6369_CR25","doi-asserted-by":"publisher","first-page":"R295","DOI":"10.1186\/ar1181","volume":"6","author":"UY Moon","year":"2004","unstructured":"Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH, Cho CS, Kim HY, Lee WK, Lee SK (2004) Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 6(4):R295-302","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"6369_CR26","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677\u20132686","journal-title":"Arthritis Rheum"},{"issue":"12","key":"6369_CR27","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1177\/0961203313493032","volume":"22","author":"A Danza","year":"2013","unstructured":"Danza A, Ruiz-Irastorza G (2013) Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 22(12):1286\u20131294","journal-title":"Lupus"},{"issue":"6","key":"6369_CR28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1177\/0961203314531637","volume":"23","author":"P Nelson","year":"2014","unstructured":"Nelson P, Rylance P, Roden D, Trela M, Tugnet N (2014) Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus 23(6):596\u2013605","journal-title":"Lupus"},{"key":"6369_CR29","doi-asserted-by":"crossref","unstructured":"AH Draborg, K Duus, G Houen (2012) Epstein-Barr virus and systemic lupus erythematosus. Clin Dev Immunol 2012(370516).","DOI":"10.1155\/2012\/370516"},{"issue":"5","key":"6369_CR30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1108296","volume":"366","author":"AS Fauci","year":"2012","unstructured":"Fauci AS, Morens DM (2012) The perpetual challenge of infectious diseases. N Engl J Med 366(5):454\u2013461","journal-title":"N Engl J Med"},{"issue":"1","key":"6369_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.rdc.2009.03.003","volume":"35","author":"R Cuchacovich","year":"2009","unstructured":"Cuchacovich R, Gedalia A (2009) Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin North Am 35(1):75\u201393","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"6369_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF01533366","volume":"14","author":"BL Bermas","year":"1994","unstructured":"Bermas BL, Petri M, Goldman D, Mittleman B, Miller MW, Stocks NI, Via CS, Shearer GM (1994) T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J Clin Immunol 14(3):169\u2013177","journal-title":"J Clin Immunol"},{"key":"6369_CR33","doi-asserted-by":"crossref","unstructured":"J Liu, H Gao, LP Xu, XD Mo, R Liu, S Liang, N Wu, M Wang, Z Wang, YJ Chang, Y Wang, XH Zhang, XJ Huang (2020) Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vdelta2(+) T cells activities after hematopoietic transplantation for blood malignancies. J Immunother Cancer 8(1).","DOI":"10.1136\/jitc-2019-000208"},{"issue":"2","key":"6369_CR34","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/ibd.21278","volume":"17","author":"E Angelucci","year":"2011","unstructured":"Angelucci E, Cesarini M, Caturelli E, Vernia P (2011) EBV hepatitis in a young Crohn\u2019s disease patient on prolonged remission with azathioprine. Inflamm Bowel Dis 17(2):E1","journal-title":"Inflamm Bowel Dis"},{"issue":"22","key":"6369_CR35","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/jnci\/djh313","volume":"96","author":"WH Feng","year":"2004","unstructured":"Feng WH, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R, Raab-Traub N, Delecluse HJ, Kenney SC (2004) Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 96(22):1691\u20131702","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"6369_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/03009742.2014.973061","volume":"44","author":"NS Rasmussen","year":"2015","unstructured":"Rasmussen NS, Draborg AH, Nielsen CT, Jacobsen S, Houen G (2015) Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients. Scand J Rheumatol 44(2):143\u2013149","journal-title":"Scand J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06369-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:14:17Z","timestamp":1672982057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06369-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["6369"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06369-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}